Login to Your Account

Epimmune Trimming Staff, Costs To Help Develop Pipeline Drugs

By Randall Osborne

Friday, September 5, 2003
Epimmune Inc. reduced its staff by 23 percent and implemented other cost-cutting measures that the company said would give it enough operating funds to pull results from ongoing clinical trials in HIV and cancer. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription